Ricardo Campello, partner, will participate in the “Biosimilars LatAm – Brazil 2024”, which will take place on August 21st and 22nd, in São Paulo. Mr. Campello will be a speaker on the panel “Navigating the Landscape of Biosimilar Licensing: Strategies for Successful Market Entry in Brazil”. The event aims to delve into the hurdles of producing monoclonal antibodies locally, discuss effective strategies for navigating the complex landscape of biosimilar licensing in Brazil, and explore the economic implications of biosimilar usage, focusing on cost savings, accessibility, and the evolving market dynamics in the country. Learn more at: https://jackleckerman.com/events/biosimilars-latam-brazil-2024/